Serial 99564933
Live / Registered — Registered (as of 20 Oct 2026)
What this means for you
Registered since 20 Oct 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 20 Oct 2032: the §8 declaration of use).
Record
- Serial number
- 99564933
- Registration number
- 8517757
- Mark type
- Design / logo
- Filed
- 24 Dec 2025
- Published for opposition
- 23 Jun 2026
- Registered
- 20 Oct 2026
- Next maintenance filing
- §8 declaration of use, due by 20 Oct 2032 (grace period to 20 Apr 2033)
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of anemia in patients with inherited blood disorders
Owner
- Agios Pharmaceuticals, Inc., Cambridge, MA, US
- Agios Pharmaceuticals, Inc., Cambridge, MA, US
- Agios Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 20 Oct 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 20 Oct 2026 — REGISTERED-PRINCIPAL REGISTER
- 01 Oct 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Oct 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 15 Sept 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 18 Aug 2026 — USE AMENDMENT FILED
- 18 Aug 2026 — TEAS STATEMENT OF USE RECEIVED
- 18 Aug 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 23 Jun 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Jun 2026 — PUBLISHED FOR OPPOSITION
- 17 Jun 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 28 May 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 May 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 13 May 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 13 May 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED